Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Slevin

Showing results (51-60 of 96) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology GroupE Wiltshaw, T J Perren, I D Fryatt, et al.
Molecular Biosystems|February 23, 2010
Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosisM Slevin, L Badimon, M Grau-Olivares, et al.
Expert Opinion on Investigational Drugs|August 13, 2008
New VEGF antagonists as possible therapeutic agents in vascular diseaseM Slevin, P Kumar, Quiyu Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Epirubicin for pretreated advanced ovarian cancerR Coleman, K Towlson, E Wiltshaw, et al.
British Journal of Cancer|January 1, 1992
British Psychological Oncology Group: seventh annual conferenceJ Morris, A Cull, L Fallowfield, et al.
British Journal of Cancer|June 1, 1995
Volunteers or victims: patients' views of randomised cancer clinical trialsM Slevin, J Mossman, A Bowling, et al.
Angiogenesis|August 29, 2002
Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetesY Duraisamy, M Slevin, N Smith, et al.
British Journal of Cancer|January 1, 1997
Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacyP N Mainwaring, M C Nicolson, T Hickish, et al.
International Journal of Clinical Pharmacology Research|January 1, 1992
Protein binding of indomethacin, methotrexate and morphine in patients with cancerR Raveendran, W M Heybroek, M Caulfield, et al.
Angiogenesis|March 12, 2008
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesisS Hussain, M Slevin, S Matou, et al.
Pageof 10

Showing results (51-60 of 96) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1990
Carboplatin and ifosfamide in ovarian cancer phase II and III trials. London Gynaecological Oncology GroupE Wiltshaw, T J Perren, I D Fryatt, et al.
Molecular Biosystems|February 23, 2010
Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosisM Slevin, L Badimon, M Grau-Olivares, et al.
Expert Opinion on Investigational Drugs|August 13, 2008
New VEGF antagonists as possible therapeutic agents in vascular diseaseM Slevin, P Kumar, Quiyu Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Epirubicin for pretreated advanced ovarian cancerR Coleman, K Towlson, E Wiltshaw, et al.
British Journal of Cancer|January 1, 1992
British Psychological Oncology Group: seventh annual conferenceJ Morris, A Cull, L Fallowfield, et al.
British Journal of Cancer|June 1, 1995
Volunteers or victims: patients' views of randomised cancer clinical trialsM Slevin, J Mossman, A Bowling, et al.
Angiogenesis|August 29, 2002
Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetesY Duraisamy, M Slevin, N Smith, et al.
British Journal of Cancer|January 1, 1997
Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacyP N Mainwaring, M C Nicolson, T Hickish, et al.
International Journal of Clinical Pharmacology Research|January 1, 1992
Protein binding of indomethacin, methotrexate and morphine in patients with cancerR Raveendran, W M Heybroek, M Caulfield, et al.
Angiogenesis|March 12, 2008
Anti-angiogenic activity of sesterterpenes; natural product inhibitors of FGF-2-induced angiogenesisS Hussain, M Slevin, S Matou, et al.
Pageof 10